Hospice Of Jefferson Co/palliative Care Of Jeffers 1398 Gotham Street, Watertown, NY, 13601 | |
(315) 788-7323 |
News Archive
Dow Jones/Wall Street Journal reports that GlaxoSmithKline announced Tuesday it has partnered with three non-governmental organizations to address the shortage of primary health care providers in least developed countries.
Less than half the population of Africa are not receiving the health services they need, with vulnerable groups including gay and disabled people left behind, says a report.
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
Patients suffering from the painful autoimmune disease, Sjogren's Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University at Buffalo and Immco Diagnostics, Inc. The breakthrough, described in a paper in the December issue of Clinical Immunology, will allow patients to be treated sooner when they are much more likely to benefit.
› Verified 8 days ago
Name | Hospice Of Jefferson Co/palliative Care Of Jeffers |
---|---|
Location | 1398 Gotham Street, Watertown, New York |
Hospice ID | 331515 |
Category | Freestanding Hospice |
Ownership Type | Voluntary Non-profit - Private |
Profit Type | NON-PROFIT |
SSA county code | 330 |
News Archive
Dow Jones/Wall Street Journal reports that GlaxoSmithKline announced Tuesday it has partnered with three non-governmental organizations to address the shortage of primary health care providers in least developed countries.
Less than half the population of Africa are not receiving the health services they need, with vulnerable groups including gay and disabled people left behind, says a report.
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
Patients suffering from the painful autoimmune disease, Sjogren's Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University at Buffalo and Immco Diagnostics, Inc. The breakthrough, described in a paper in the December issue of Clinical Immunology, will allow patients to be treated sooner when they are much more likely to benefit.
› Verified 8 days ago
NPI Number | 1164426433 |
Organization Name | Hospice Of Jefferson County, Inc. |
Address | 1398 Gotham Street Watertown, New York, 13601 |
Phone Number | (315)788-7323 |
News Archive
Dow Jones/Wall Street Journal reports that GlaxoSmithKline announced Tuesday it has partnered with three non-governmental organizations to address the shortage of primary health care providers in least developed countries.
Less than half the population of Africa are not receiving the health services they need, with vulnerable groups including gay and disabled people left behind, says a report.
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
Patients suffering from the painful autoimmune disease, Sjogren's Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University at Buffalo and Immco Diagnostics, Inc. The breakthrough, described in a paper in the December issue of Clinical Immunology, will allow patients to be treated sooner when they are much more likely to benefit.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 97.7 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 92.5 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 89.1 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 88.5 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | 98.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 97.0 | 93.3 |
News Archive
Dow Jones/Wall Street Journal reports that GlaxoSmithKline announced Tuesday it has partnered with three non-governmental organizations to address the shortage of primary health care providers in least developed countries.
Less than half the population of Africa are not receiving the health services they need, with vulnerable groups including gay and disabled people left behind, says a report.
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
Patients suffering from the painful autoimmune disease, Sjogren's Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University at Buffalo and Immco Diagnostics, Inc. The breakthrough, described in a paper in the December issue of Clinical Immunology, will allow patients to be treated sooner when they are much more likely to benefit.
› Verified 8 days ago
Counselors | 1 |
Licensed Practical or Vocational Nurses | 11.5 |
Medical Social Workers | 2 |
Registered Nurses | 10 |
Other Personnel | 11 |
Total Employees | 35.5 |
---|
News Archive
Dow Jones/Wall Street Journal reports that GlaxoSmithKline announced Tuesday it has partnered with three non-governmental organizations to address the shortage of primary health care providers in least developed countries.
Less than half the population of Africa are not receiving the health services they need, with vulnerable groups including gay and disabled people left behind, says a report.
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
Patients suffering from the painful autoimmune disease, Sjogren's Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University at Buffalo and Immco Diagnostics, Inc. The breakthrough, described in a paper in the December issue of Clinical Immunology, will allow patients to be treated sooner when they are much more likely to benefit.
› Verified 8 days ago
Physicians | 2 |
Total Volunteers | 2 |
---|
News Archive
Dow Jones/Wall Street Journal reports that GlaxoSmithKline announced Tuesday it has partnered with three non-governmental organizations to address the shortage of primary health care providers in least developed countries.
Less than half the population of Africa are not receiving the health services they need, with vulnerable groups including gay and disabled people left behind, says a report.
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
Patients suffering from the painful autoimmune disease, Sjogren's Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University at Buffalo and Immco Diagnostics, Inc. The breakthrough, described in a paper in the December issue of Clinical Immunology, will allow patients to be treated sooner when they are much more likely to benefit.
› Verified 8 days ago
Hospice Of Jefferson Co/palliative Care Of Jeffers Location: 1398 Gotham Street, Watertown, New York, 13601 Phone: (315) 788-7323 |